Clinical Trial Update: Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission. [Phase 2]

View source ↗

Summary

A phase 2 trial is evaluating combining Inaticabtagene Autoleucel CAR-T therapy with autologous hematopoietic stem cell transplantation in adolescents or adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Inaticabtagene Autoleucel

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING